From: http://www.voicesforvaccines.org/leaving-the-anti-vaccine-movement/
I can’t tell you how I became pro-vaccine without first telling you how I became anti-vaccine.
When my oldest daughter was about four months old, I discovered “crunchy” parenting. I entered a world full of cloth diapers, “intactivism,” and home birth. I made a lot of new friends who shared my beliefs about peaceful attachment parenting, and I started to notice a trend – many of these same friends also didn’t vaccinate. I discussed it one day with a real-life friend, who told me I should look up vaccine ingredients, read the package inserts, and check out the adverse events reported on VAERS.
So I did a Google search for “vaccine ingredients” and was shocked by what I found. Could there really be all of these nasty-sounding ingredients in vaccines, I wondered? I went to the CDC’s website and found package inserts. I didn’t understand much of what I read, but it did sound pretty scary. I looked up the prevalence of diseases today and realized that nobody had even caught diphtheria for years! I was confused, and my daughter’s six-month check up was coming up. I opted out of vaccines then, telling the doctor I wanted to do some more research before we went any further.
However, my research was very skewed. I was going into it with preconceived ideas – my anti-vaccine friends had put ideas into my head, such as not trusting government websites. I was forced to rely on whatever I could find while Googling, which were often websites like Mercola or whale.to. I even started “liking” anti-vaccine pages on Facebook – pages that I now understand masquerade as “information” centers. I got added to Facebook groups like “Great Mothers Questioning Vaccines.”
Even though all of my supposed research was coming from non-scientific sources, I trusted it.
Then I got pregnant with our second child and planned a home birth. My midwives were very supportive of my anti-vaccination stance. My second daughter was born at home, and for months I prided myself on the fact that she had never been “injected with anything.” I even bragged about how we didn’t take her to the doctor until she was six months old.
My friends, too, were supportive. They reassured me that my breast milk was protecting her from disease, and how she was a shining example of a healthy unvaccinated child. I was proud to have a sense of community with other mothers who shared my views and who cheered me on.
However, I’ve always considered myself a skeptic, and I began to notice how some of my anti-vaccine friends believed in some other things that I found, well, questionable. For example, several of my anti-vaccine friends posted about chemtrails pretty frequently. I’d never heard of chemtrails, so I did some research and quickly discovered it was just a conspiracy theory easily explained away by people who actually understood how airplane contrails work. I also noticed that skeptic pages I followed occasionally made jabs about “anti-vaxxers” and homeopaths.
It was a slow process, but I gradually began to question my own anti-vaccine views. I stopped posting about vaccines for several months and began seeking out real science that would show me the truth, either way. What I found shocked me.
Anti-vaccine people had told me countless times that safety studies on vaccines were extremely lacking, but I was able to pull up hundreds of studies with just a few PubMed searches. They had told me that better hygiene and sanitation had been responsible for the massive decreases in disease, not vaccines—but I was able to find graphs and information from the CDC proving this wasn’t the case.
Graph: http://www.voicesforvaccines.org/wpvfv/wp-content/uploads/2014/02/c6fb5feb7f1...
I was told vaccines overload the immune system. “Too many too soon” was burned into my brain, but then I learned things like this:
Graph: http://www.voicesforvaccines.org/wpvfv/wp-content/uploads/2014/02/229292c4ddf...
In the end, I couldn’t continue to deny the science. It’s hard to believe now how easily I bought into everything I was hearing from the anti-vaccine crowd. It seems extremely obvious now: doctors aren’t evil, scientists aren’t trying to kill your kids with toxins, and vaccine researchers aren’t just trying to scam you out of your money.
When my youngest daughter was ten months old, I had finally made up my mind. It was time to start vaccinating again. It had been a two-year journey that took me from one end of the spectrum to the other, but at least this time I’ve got science on my side. Both of my girls are in the process of catching up on their vaccines now. They’re getting immunizations in the same order they would have gotten them at a younger age.
Both handled their first round of shots just fine, without even a fever. If it weren’t for the tiny bruises on their legs, you wouldn’t even know they’d just gotten shots. I’m proud to be a vaccinating mom now, to be giving my children the best shot at a healthy life.
The fallout from changing my views was pretty extreme. Within two weeks of “coming out” on Facebook about my new stance, I lost over 50 friends. People who had cheered me on and supported me through my home birth, who had told me countless times that I was an awesome mother and an inspiration, just dropped me like we’d never been friends at all. I was removed from groups and blocked by people I didn’t even know. I was accused of being brainwashed and told that my girls were going to get autism and have terrible reactions. It hurt.
I now view the anti-vaccine movement as a sort of cult, where any sort of questioning gets you kicked out, your crunchy card revoked. I was even told I couldn’t call myself a natural mother anymore, because vaccines are too unnatural. That’s fine. I just want to be the best parent I know how to be, and that means always being open to new information and admitting when I’m wrong.
I was terribly wrong about vaccines, and I’m thankful my girls never caught anything. I feel like I’m being more true to myself, now, as well. I’m not blindly following what others say, just because we agree on a few other things. I’m putting my trust in science, and discovering who were really my friends all along.
Megan Sandlin is a 20-year-old mother of two. She, her husband, and her children live together in the Midwest. When not playing with her children, Megan blogs about motherhood and parenting.
We all get to pick her own poisons [except our kids]
If she's happy, I'm happy for her. Wish her and family good luck.
http://www.youtube.com/watch?v=6S1-LgYyjQg
No studies or scientific evidence? An erroneous meme perpetuated once again!
From PubMed: 70+ recent studies done by researchers world-wide and published in well know journals just focusing on vaccine safety with flu vaccinations:
Greene SK, Kulldorff M, Lewis EM et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am. J. Epidemiol. 171(2), 177–188(2010).
Lee GM, Greene SK, Weintraub ES et al.; Vaccine Safety Datalink Project. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am. J. Prev. Med. 41(2), 121–128(2011).
Wright PF, Sell SH, Thompson J, Karzon DT. Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. J. Pediatr. 88(1), 31–35(1976).
Vasil'eva RI, Merkur'eva LA, Iatsenko VG, Vasil'eva AM, Shvager MM. Characteristics of the clinical and immunologic safety of inactivated influenza vaccines in children undergoing multiple immunizations. Zh. Mikrobiol. Epidemiol. Immunobiol. 11, 65–69(1988).
Beutner KR, Chow T, Rubi E, Strussenberg J, Clement J, Ogra PL. Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. J. Infect. Dis. 140(6), 844–850(1979).
Barry DW, Mayner RE, Hochstein HD et al. Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am. J. Epidemiol. 104(1), 47–59(1976).
France EK, Glanz JM, Xu S et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch. Pediatr. Adolesc. Med. 158(11), 1031–1036(2004).
Glanz JM, Newcomer SR, Hambidge SJ et al. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. Arch. Pediatr. Adolesc. Med. 165(8), 749–755(2011).
Hambidge SJ, Glanz JM, France EK et al.; Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA 296(16), 1990–1997(2006).
(Provides information on the safety of inactivated influenza vaccine in a large population of children 6–23 months of age.)
El'shina GA, Gorbunov MA, Bektimirov TA et al. The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren. Zh. Mikrobiol. Epidemiol. Immunobiol. (2), 50–54(2000).
Baxter R, Jeanfreau R, Block SL et al. A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children. Pediatr. Infect. Dis. J. 29(10), 924–930(2010).
Bohlke K, Davis RL, Marcy SM et al.; Vaccine Safety Datalink Team. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112(4), 815–820(2003).
Kelso JM. Administration of influenza vaccines to patients with egg allergy. J. Allergy Clin. Immunol. 125(4), 800–802(2010).
Kelso JM, Li JT, Nicklas RA et al.; Joint Task Force on Practice Parameters; Joint Task Forcce on Practice Parameters for Allergy & Immunology. Adverse reactions to vaccines. Ann. Allergy Asthma Immunol. 103(4 Suppl. 2), S1–S14(2009).
Kelso JM. Update on vaccination guidelines for allergic children. Expert Rev. Vaccines 8(11), 1541–1546(2009).
Wood RA, Berger M, Dreskin SC et al.; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 122(3), e771–e777(2008).
Armstrong PK, Dowse GK, Effler PV et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open 1(1), e000016(2011).
(Provides results of epidemiologic investigations of febrile seizure following administration of inactivated influenza vaccine in Western Australia.)
Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age. Vaccine 27(32), 4278–4283(2009).
McMahon AW, Iskander J, Haber P et al. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990–2003. Pediatrics 115(2), 453–460(2005).
Wood N, Sheppeard V, Cashman P et al. Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia. Pediatr. Infect. Dis. J. 31(2), 199–202(2012).
Blyth CC, Currie AJ, Wiertsema SP et al. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine 29(32), 5107–5113(2011).
Varricchio F, Iskander J, Destefano F et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr. Infect. Dis. J. 23(4), 287–294(2004).
Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010–2011. Vaccine 30(11), 2024–2031(2012).
Nohynek H, Jokinen J, Partinen M et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7(3), e33536(2012).
Partinen M, Saarenpää-Heikkilä O, Ilveskoski I et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 7(3), e33723(2012).
Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age. Vaccine 26(Suppl. 4), D10–D16(2008).
Bergen R, Black S, Shinefield H et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr. Infect. Dis. J. 23(2), 138–144(2004).
Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr. Infect. Dis. J. 27(5), 444–452(2008).
King JC Jr, Lagos R, Bernstein DI et al. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J. Infect. Dis. 177(5), 1394–1397(1998).
Nolan T, Lee MS, Cordova JM et al. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. Vaccine 21(11–12), 1224–1231(2003).
Piedra PA, Gaglani MJ, Riggs M et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics 116(3), e397–e407(2005).
Piedra PA, Yan L, Kotloff K et al. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children. Pediatrics 110(4), 662–672(2002).
Redding G, Walker RE, Hessel C et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J. 21(1), 44–48(2002).
Zangwill KM, Droge J, Mendelman P et al. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Pediatr. Infect. Dis. J. 20(8), 740–746(2001).
Desheva IUA, Danini GV, Grigor'eva EP et al. The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3–6 years old children. Vopr. Virusol. 47(4), 21–24(2002).
Gruber WC, Belshe RB, King JC et al. Evaluation of live attenuated influenza vaccines in children 6–18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group. J. Infect. Dis. 173(6), 1313–1319(1996).
Nolan T, Bernstein DI, Block SL et al.; LAIV Study Group. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics 121(3), 508–516(2008).
Baxter R, Toback SL, Sifakis F et al. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18–49 years of age. Vaccine 30(20), 3053–3060(2012).
Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ 307(6910), 988–990(1993).
(Results of a randomized controlled trial to investigate the frequency and type of adverse events following administration of influenza vaccine among the elderly.)
Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 264(9), 1139–1141(1990).
Keitel WA, Atmar RL, Cate TR et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch. Intern. Med. 166(10), 1121–1127(2006).
Schwarz TF, Flamaing J, Rümke HC et al. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged =65 years. Vaccine 29(32), 5195–5202(2011).
Weston WM, Chandrashekar V, Friedland LR, Howe B. Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults. Hum. Vaccin. 5(12), 858–866(2009).
Kerzner B, Murray AV, Cheng E et al. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older. J. Am. Geriatr. Soc. 55(10), 1499–1507(2007).
McNeil SA, Noya F, Dionne M et al. Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults. Vaccine 25(17), 3464–3474(2007).
Sejvar JJ, Kohl KS, Gidudu J et al.; Brighton Collaboration GBS Working Group. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29(3), 599–612(2011).
Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al. Guillain–Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am. J. Epidemiol. 110(2), 105–123(1979).
(Results of epidemiologic investigations of Guillain–Barré syndrome following administration of a swine influenza virus vaccine during a national immunization program.)
Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain–Barré syndrome and the 1978–1979 influenza vaccine. N. Engl. J. Med. 304(26), 1557–1561(1981).
Kaplan JE, Katona P, Hurwitz ES, Schonberger LB. Guillain–Barré syndrome in the United States, 1979–1980 and 1980–1981. Lack of an association with influenza vaccination. JAMA 248(6), 698–700(1982).
Burwen DR, Ball R, Bryan WW et al. Evaluation of Guillain–Barré Syndrome among recipients of influenza vaccine in 2000 and 2001. Am. J. Prev. Med. 39(4), 296–304(2010).
Hughes RA, Charlton J, Latinovic R, Gulliford MC. No association between immunization and Guillain–Barré syndrome in the United Kingdom, 1992 to 2000. Arch. Intern. Med. 166(12), 1301–1304(2006).
Roscelli JD, Bass JW, Pang L. Guillain–Barré syndrome and influenza vaccination in the US Army, 1980–1988. Am. J. Epidemiol. 133(9), 952–955(1991).
Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain–Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am. J. Epidemiol. 169(3), 382–388(2009).
Lasky T, Terracciano GJ, Magder L et al. The Guillain–Barré syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N. Engl. J. Med. 339(25), 1797–1802(1998).
Juurlink DN, Stukel TA, Kwong J et al. Guillain–Barré syndrome after influenza vaccination in adults: a population-based study. Arch. Intern. Med. 166(20), 2217–2221(2006).
Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; CISA Network. Recurrent Guillain–Barré syndrome following vaccination. Clin. Infect. Dis. 54(6), 800–804(2012).
Moro PL, Broder K, Zheteyeva Y et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am. J. Obstet. Gynecol. 205(5), 473.e1–473.e9(2011).
Salmon DA, Akhtar A, Mergler MJ et al.; H1N1 Working Group of Federal Immunization Safety Task Force. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics 127(Suppl. 1), S78–S86(2011).
Williams SE, Pahud BA, Vellozzi C et al. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 29(46), 8302–8308(2011).
Andrews N, Stowe J, Al-Shahi Salman R, Miller E. Guillain–Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 29(45), 7878–7882(2011).
Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M; VAESCO-GBS Case-Control Study Group. Guillain–Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 343, d3908(2011).
Preliminary results: surveillance for Guillain–Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine – United States, 2009–2010. MMWR Morb. Mortal Wkly. Rep. 59(21), 657–661(2010).
Greene SK, Rett M, Weintraub ES et al. Risk of confirmed Guillain–Barré syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009–2010. Am. J. Epidemiol. 175(11), 1100–1109(2012).
Wise ME, Viray M, Sejvar JJ et al. Guillain–Barré syndrome during the 2009–2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am. J. Epidemiol. 175(11), 1110–1119(2012).
Jackson LA, Holmes SJ, Mendelman PM, Huggins L, Cho I, Rhorer J. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. Vaccine 17(15–16), 1905–1909(1999).
Halperin SA, Nestruck AC, Eastwood BJ. Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture. Vaccine 16(13), 1331–1335(1998).
Groth N, Montomoli E, Gentile C, Manini I, Bugarini R, Podda A. Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial. Vaccine 27(5), 786–791(2009).
Palache AM, Brands R, van Scharrenburg GJ. Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. J. Infect. Dis. 176(Suppl. 1), S20–S23(1997).
Palache AM, Scheepers HS, de Regt V et al. Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies. Dev. Biol. Stand. 98, 115–25; discussion 133(1999).
Halperin SA, Smith B, Mabrouk T et al. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine 20(7–8), 1240–1247(2002).
Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. J. Infect. Dis. 200(6), 849–857(2009).
Keitel W, Groth N, Lattanzi M et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a Phase 1/2 clinical trial. Vaccine 28(3), 840–848(2010).
Szymczakiewicz-Multanowska A, Groth N, Bugarini R et al. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. J. Infect. Dis. 200(6), 841–848(2009).
López-Macías C, Ferat-Osorio E, Tenorio-Calvo A et al. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico. Vaccine 29(44), 7826–7834(2011).
Lewis DJ, Huo Z, Barnett S et al. Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS ONE 4(9), e6999(2009).
Mutsch M, Zhou W, Rhodes P et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 350(9), 896–903(2004).
Nicholson KG, Abrams KR, Batham S et al. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect. Dis. 11(2), 91–101(2011).
Baxter R, Patriarca PA, Ensor K, Izikson R, Goldenthal KL, Cox MM. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age. Vaccine 29(12), 2272–2278(2011).
Zoho said, "No studies or scientific evidence? An erroneous meme perpetuated once again!"
You minimized kwanyin's statement. Here is what was stated.
"-There are no Independent double-blind, placebo-controlled study that can prove the safety and effectiveness of vaccines."
This is true, there has never been studies of vaccinated and non-vaccinated placebo controlled studies. NEVER.
"-There is no scientific evidence on ANY study which can confirm the long-term safety and effectiveness of vaccines."
None of the studies you listed were long term studies. NOT EVEN ONE.
"-There is no scientific evidence which can prove that disease reduction in any part of the world, at any point in history was attributable to inoculation of populations."
It is true the evidence presented is not scientifically compelling. It is psyentifically compelling though for those that believe in the efficacy of the vaccine injection ritual.
It seems as though your statement is "An erroneous meme perpetuated once again!" Supported by the Corporate(non-spiritual) pharmaceutical industry whose bottom line is profit, as stated in their corporate charters.
New research shows that well-child doctor appointments for annual exams and vaccinations are associated with an increased risk of flu-like illnesses in children and family members within two weeks of the visit.
This risk translates to more than 700,000 potentially avoidable illnesses each year, costing more than $490 million annually. The study was published in the March issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
"Well child visits are critically important. However, our results demonstrate that healthcare professionals should devote more attention to reducing the risk of spreading infections in waiting rooms and clinics. Infection control guidelines currently exist. To increase patient safety in outpatient settings, more attention should be paid to these guidelines by healthcare professionals, patients, and their families," said Phil Polgreen, MD, MPH, lead author of the study.
Researchers from the University of Iowa used data from the Agency for Healthcare Research and Quality's (AHRQ) Medical Expenditure Panel Survey to examine the healthcare trends of 84,595 families collected from 1996-2008. Included in the analysis were demographic, office-based, emergency room, and outpatient cases records. After controlling for factors, such as the presence of other children, insurance, and demographics, the authors found that well-child visits for children younger than six years old increased the probability of a flu-like illness in these children or their families during the subsequent two weeks by 3.2 percentage points.
This incremental risk could amount to more than 700,000 avoidable cases of flu-like illness each year and $492 million in direct and indirect costs, based on established estimates for outpatient influenza.
In a commentary accompanying the study, Lisa Saiman, MD, notes, "The true cost of flu-like illnesses are much higher since only a fraction result in ambulatory visits and many more cases are likely to result in missed work or school days. Furthermore, these flu-like illness visits are associated with inappropriate antimicrobial use."
The authors stress the importance of infection prevention and control in ambulatory settings, suggesting pediatric clinics follow recommended guidelines that include improving environmental cleaning, cough etiquette, and hand hygiene compliance.
"Even with interventions, such as the restricted use of communal toys or separate sick and well-child waiting areas, if hand-hygiene compliance is poor, and potentially infectious patients are not wearing masks, preventable infections will continue to occur," said Polgreen.
www.naturalblaze.com/2014/02/well-child-and-vaccine-visits-linked-to.html
Just days after a U.K. father was sentenced to life in prison for allegedly killing his own daughter, who reportedly died from unusual head injuries after receiving the MMR vaccine for measles, mumps and rubella, an American father received the same sentence following the oddly similar death of his 12-week-old baby girl.
VacTruth.com reports that John Sanders of Lansing, Michigan, has been sentenced to life in prison without parole after botched court proceedings found him guilty of murdering his 12-week-old daughter Ja'Nayjah. The girl is said to have experienced severe brain hemorrhaging and gastrointestinal problems just 24 days after receiving eight vaccinations in one day, horrific side effects that were ultimately blamed on her dad.
Problems began when young Ja'Nayjah was first released from the hospital following her birth. Her mother Marrie says Ja'Nayjah was a healthy, normal and happy baby -- that is until she received her first round of routine vaccinations. Two days later at a routine checkup, Ja'Nayjah was found to have lost a few pounds, prompting the doctor to call her back in for tests.
Since Ja'Nayjah was already scheduled to come back in for more vaccinations, Marrie decided to wait until this date to have her daughter evaluated. But shortly before her scheduled appointment, Ja'Nayjah's health rapidly deteriorated. And instead of holding off on administering any more vaccinations until the child was better, Ja'Nayjah's doctor decided to just go ahead and jab her.
"After Ja'Nayjah came home from receiving her shots, she just wasn't the same baby anymore," recalls the girl's mother.
"Before, she was this cheerful, happy baby, but after, she just changed and wasn't as bright and cheerful as she once was. She started wheezing, was congested and was still throwing up. And when she cried, she would scream an unusual scream, almost as [if] she [were] screaming in pain. After her shots, her dad bought some infant Tylenol, which I would give her twice a day."
Dismissing these and other adverse events as normal, or consequences of the child allegedly "eating too much," the doctor in question convinced Marrie that her daughter was fine. But this turned out not to be the case, as young Ja'Nayjah suffered severe brain trauma just 24 days after receiving vaccines for DTaP, polio, rotavirus, hepatitis B, meningitis and Hib.
According to Marrie's account of what happened, Ja'Nayjah was irritable on the day before she was left in the care of her father, who found the child unconscious and not breathing the day she died. He had been preparing a bottle for her when she suddenly stopped crying, upon which he rushed her to the hospital. But it was already too late.
"While at the hospital, she had to have emergency brain surgery and blood transfusions," recalls Marrie. "She died in my arms after spending about 12 hours in the hospital."
But rather than assess the situation fairly by looking at the vaccination issue, authorities charged Ja'Nayjah's father with murder. He was immediately arrested and accused of shaking his baby to death, a medical condition marked by the very same injuries that science has found can result from vaccine adverse events.
Since young Ja'Nayjah was sick both prior to and during the time when she died, any number of things could have caused her death. VacTruth.com's Christina England explains how vitamin C deficiency caused by vaccine overload; brain injuries caused by the toxic adjuvants in the vaccines; and pre-existing health conditions, which were ignored by Ja'Nayjah's doctor, are all possible causes of the girl's death that were ignored by the courts.
"This case was completely one-sided, hinging on weak, flimsy evidence, all of which was completely circumstantial," writes England.
Be sure to read her full report on the case, which is in the process of being appealed, here:
http://vactruth.com.
Sources for this article include:
http://vactruth.com
http://www.naturalnews.com
http://science.naturalnews.com